Overexpression of phosphatidylinositol 4-kinase type IIIα is associated with undifferentiated status and poor prognosis of human hepatocellular carcinoma

被引：0
|
作者：
Adeodat Ilboudo
Jean-Charles Nault
Hélène Dubois-Pot-Schneider
Anne Corlu
Jessica Zucman-Rossi
Michel Samson
Jacques Le Seyec
机构：
[1] INSERM,
[2] UMR-1085,undefined
[3] Institut de Recherche Santé Environnement & Travail (IRSET),undefined
[4] INSERM,undefined
[5] UMR-991,undefined
[6] Liver Metabolisms and Cancer,undefined
[7] Université de Rennes 1,undefined
[8] Fédération de Recherche BioSit de Rennes,undefined
[9] INSERM,undefined
[10] UMR-674,undefined
[11] Génomique fonctionnelle des tumeurs solides,undefined
[12] IUH,undefined
[13] Université Paris Descartes,undefined
[14] Labex Immuno-oncology,undefined
[15] Sorbonne Paris Cité,undefined
[16] Faculté de Médecine,undefined
来源：
BMC Cancer | / 14卷
关键词：
Hepatocellular carcinoma; PI4KA; Biomarker; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Overexpression of Pyruvate Kinase M2 in Tumor Tissues Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma
    Zhao, Rui
    Li, Lei
    Yang, Jinbo
    Niu, Qinfeng
    Wang, Han
    Qin, Xiaodong
    Zhu, Ning
    Shi, Anchen
    PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (02) : 853 - 860
  • [22] Cloning of a human type II phosphatidylinositol 4-kinase reveals a novel lipid kinase family
    Minogue, S
    Anderson, JS
    Waugh, MG
    dos Santos, M
    Corless, S
    Cramer, R
    Hsuan, JJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (20) : 16635 - 16640
  • [23] Overexpression of YTHDF1 is associated with poor prognosis in patients with hepatocellular carcinoma
    Zhao, Xianguang
    Chen, Yang
    Mao, Qiqi
    Jiang, Xiaoyun
    Jiang, Weiru
    Chen, Jiajie
    Xu, Weijia
    Zhong, Liang
    Sun, Xu
    CANCER BIOMARKERS, 2018, 21 (04) : 859 - 868
  • [24] EXO1 overexpression is associated with poor prognosis of hepatocellular carcinoma patients
    Dai, Yaoyao
    Tang, Zuxiong
    Yang, Zongguo
    Zhang, Lan
    Deng, Qing
    Zhang, Xiaofeng
    Yu, Yongchun
    Liu, Xing
    Zhu, Junfeng
    CELL CYCLE, 2018, 17 (19-20) : 2386 - 2397
  • [25] NDRG3 overexpression is associated with a poor prognosis in patients with hepatocellular carcinoma
    Jing, Ji-sheng
    Li, Hongbo
    Wang, Shun-cai
    Ma, Jiu-ming
    Yu, La-qing
    Zhou, Hua
    BIOSCIENCE REPORTS, 2018, 38
  • [26] The mTOR pathway is associated with the poor prognosis of human hepatocellular carcinoma
    Ledu Zhou
    Yun Huang
    Jingdong Li
    Zhiming Wang
    Medical Oncology, 2010, 27 : 255 - 261
  • [27] The mTOR pathway is associated with the poor prognosis of human hepatocellular carcinoma
    Zhou, Ledu
    Huang, Yun
    Li, Jingdong
    Wang, Zhiming
    MEDICAL ONCOLOGY, 2010, 27 (02) : 255 - 261
  • [28] A poor prognosis in human hepatocellular carcinoma is associated with low expression of DPP4
    Yu, Hao
    Mei, Xiao-Ping
    Su, Peng-Fei
    Jin, Guang-Zhi
    Zhou, Hong-Kun
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2020, 53 (04)
  • [29] Vemurafenib Inhibits Acute and Chronic Enterovirus Infection by Affecting Cellular Kinase Phosphatidylinositol 4-Kinase Type IIIβ
    Laajala, Mira
    Zwaagstra, Marleen
    Martikainen, Mari
    Nekoua, Magloire Pandoua
    Benkahla, Mehdi
    Sane, Famara
    Gervais, Emily
    Campagnola, Grace
    Honkimaa, Anni
    Sioofy-Khojine, Amir-Babak
    Hyoety, Heikki
    Ojha, Ravi
    Bailliot, Marie
    Balistreri, Giuseppe
    Peersen, Olve
    Hober, Didier
    Van Kuppeveld, Frank
    Marjomaeki, Varpu
    MICROBIOLOGY SPECTRUM, 2023, 11 (04):
  • [30] Amyloid β proteins inhibit recombinant human type II phosphatidylinositol 4-kinase α activity
    Wu, B
    Kitagawa, K
    Zhang, NY
    Inagaki, C
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 94 : 290P - 290P
12345